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https://doi.org/10.1016/j.stemcr.2017.11.020SUMMARYTransition from primed to naive pluripotency is associated with dynamic changes in transposable element (TE) expression and demethy-
lation of imprinting control regions (ICRs). In mouse, ICR methylation and TE expression are each regulated by TRIM28; however, the
role of TRIM28 in humans is less clear. Here, we show that a null mutation in TRIM28 causes significant alterations in TE expression in
both the naive and primed states of human pluripotency, and phenotypically this has limited effects on self-renewal, instead causing a
loss of germline competency. Furthermore, we discovered that TRIM28 regulates paternal ICR methylation and chromatin accessibility
in the primed state, with no effects on maternal ICRs. Taken together, our study shows that abnormal TE expression is tolerated by
self-renewing human pluripotent cells, whereas germline competency is not.INTRODUCTION
Most studies on the mechanisms that regulate human
pluripotency have focused on protein-coding genes, which
constitute less than 5% of the human genome. In contrast,
TEs, which account for nearly half the human genome,
have received significantly less attention. Recent reports
have shown that TEs are dynamically expressed in human
germline cells, the naive and primed states of human plu-
ripotency, human pre-implantation embryos, and human
germ cell tumors (Go¨ke et al., 2015; Grow et al., 2015;
Herbst et al., 1996; Lu et al., 2014; Theunissen et al.,
2016; Wang et al., 2014). Yet the mechanisms that regulate
the dynamic expression of TEs in human pluripotency and
human germline development are not well understood.
One of themost dynamically expressed families of TEs in
human pre-implantation embryos are long terminal repeat
(LTR) retrotransposons, which constitute about 8% of the
human genome (Cordaux and Batzer, 2009). Notably,
full-length human-specific LTR5 (LTR5_HS) human endog-
enous retroviral K (HERVK) TEs are expressed exclusively in
8-cell, morula, and pre-implantation human epiblast cells
as well as in germ cell tumors (Grow et al., 2015; Herbst
et al., 1996). In contrast, the primate-specific LTR7-
HERVHs are expressed throughout human pre-implanta-
tion embryo development as well as in primed human
embryonic stem cells (hESCs), but are repressed when
primed hESCs are converted to the naive state (Theunissen
et al., 2016). LTR5_HS TEs regulate viral infection in humanStem Cell R
This is an open access artipluripotent stem cells, whereas LTR7-HERVHs regulate
primed pluripotent stem cell self-renewal (Go¨ke et al.,
2015; Grow et al., 2015; Lu et al., 2014; Wang et al., 2014).
Dynamic TE expression is not restricted to human
embryos. In the mouse embryo, murine endogenous retro-
virus L (MuERV-L) is expressed at the 2-cell and 8-cell stage
of mouse embryo development, whereas intracisternal A
particles (IAPs) are expressed in mouse oocytes, cleavage
embryos, and blastocysts (Svoboda et al., 2004). Long
interspersed nuclear element 1 (LINE1), a non-LTR TE, is
expressed during mouse zygotic genome activation where
it functions to enable chromatin accessibility (Fadloun
et al., 2013; Jachowicz et al., 2017; Rowe et al., 2010).
Therefore TE expression in germline competent pluripo-
tent cells in both mouse and human is a fundamental
requirement for pluripotent cell biology.
Although regulation of TE expression in human embryos
and pluripotent stem cells is not well known, one of the
major mechanisms responsible for regulating TE expres-
sion in mouse embryos is Trim28 (also named Kap1 and
Tif1b) (Schultz et al., 2001, 2002; Wolf and Goff, 2007;
Zuo et al., 2012). In mouse, a zygotic knockout of Trim28
causes embryonic lethality shortly after implantation
(Cammas et al., 2000), whereas amaternalmouse knockout
causes variable epigenetic instability at imprinting control
regions (ICRs), and no live births (Messerschmidt et al.,
2012). In naive mouse ESCs, Trim28 is essential for repres-
sion of IAPs, as well as mouse ESC self-renewal and survival
(Rowe et al., 2010), whereas in primed hESCs, a short-termeports j Vol. 10 j 243–256 j January 9, 2018 j ª 2017 The Author(s). 243
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knockdown of TRIM28 leads to HERV derepression (Turelli
et al., 2014); however, the role of TRIM28 in the basic
properties of human primed or naive pluripotency is not
known.
In the current study we report the generation of TRIM28
null mutations in primed and naive hESCs using clustered
regularly interspaced short palindromic repeats (CRISPR)/
CRISPR-associated protein nuclease (Cas9) technology
(Cong et al., 2013). We show that a null mutation in
TRIM28 is compatible with both primed and naive human
self-renewal, despite massive derepression of TEs. We
demonstrate that a null mutation in TRIM28 leads to loss
of human germline competency from primed hESCs,
indicating that it is the ability to differentiate into
the germline, not pluripotent self-renewal per se, that is
particularly sensitive to loss of TRIM28 in humans.RESULTS
TRIM28 Is Not Required for Primed hESC Self-Renewal
To evaluate the function of TRIM28 in primed hESCs, we
generated targeted deletions of TRIM28 in the genome
using CRISPR/Cas9 in the karyotypically normal 46XX
UCLA1 and 46XY UCLA6 hESC lines (Diaz Perez et al.,
2012). To achieve this, we designed paired guide RNAs
(gRNAs) that targeted exon 4 and exon 11 of human
TRIM28 (Figure S1A). Following co-electroporation of plas-
mids expressing the gRNAs and Cas9, individual clones
were picked and genotyped. A total of 112 UCLA1 and
48 UCLA6 clones were screened, and we identified two po-
tential homozygousmutant hESC clones inUCLA1 that we
called TRIM28 knockout (T28KO) UCLA1-9 (U1-9) and
UCLA1-11 (U1-11) and one homozygous mutant in
UCLA6 called T28KO U6. Control (Ctrl) clones in UCLA1
and UCLA6 hESC lines were created by electroporating
Cas9 without gRNAs. To identify the precise mutation,
we performed PCR followed by cloning and Sanger
sequencing of individual alleles from the T28KO genome
(Figure S1A). Western blot analysis was used to confirm
that the TRIM28 protein was not expressed in any of the
three sublines of T28KO hESCs relative to Ctrls (Figure 1A).
Therefore, we conclude that our gene-editing approach
creates null TRIM28 mutations in primed hESCs.
Unlike in mouse where a null mutation in Trim28 leads
to defects in mouse ESC self-renewal, T28KO hESC lines
were capable of self-renewal, maintaining a morphology
of round, tightly packed colonies that were indistinguish-
able from Ctrl (Figure S1B). Analysis of cell number after
passaging T28KO and Ctrl UCLA1 sublines revealed that
on average T28KO hESC cultures had more cells on day 7
after plating compared with the Ctrl (Figure 1B), suggesting
that T28KO hESCs grow faster. We also discovered that244 Stem Cell Reports j Vol. 10 j 243–256 j January 9, 2018T28KO hESCs are karyotypically normal, even after more
than ten passages of culture (Figure S1C). Furthermore,
T28KO hESCs expressed typical markers of self-renewal
and pluripotency including OCT4 (Figure 1C), and were
capable of teratoma formation when transplanted into
immunocompromised mice (Figure 1D). Although the
teratomas contained cell types from the three somatic
lineages based on histology, the T28KO teratomas were
darkly pigmented upon necropsy, and histological analysis
indicated an abundance of highly pigmented somatic cells
(Figure S2A). These pigmented cells were rarely identified in
teratomas derived from Ctrl hESCs. Therefore, our data
indicate that a null mutation in TRIM28 has no effect on
self-renewal or pluripotency in primed conditions; instead,
it is associated with faster growth and a preference for
generating pigmented somatic cells in teratoma assays
together with cell types representing the major somatic
embryonic layers.
TRIM28 Is Required for Germline Competency
Although the teratoma assay is a non-quantitative method
for assessing the ability to differentiate into somatic cells, it
provides no clues as to whether hESC lines are germline
competent. To address this, we differentiated Ctrl and
T28KO hESCs into human primordial germ cell-like cells
(hPGCLCs) following the protocol established by Sasaki
et al. (2015). In this approach, hPGCLCs are differentiated
through a two-step protocol involving 24 hr of adherent
differentiation to create incipient mesoderm-like cells
(iMeLCs), followed by aggregate differentiation in 96-well
plates to create aggregates containinghPGCLCs (Figure 2A).
To identify hPGCLCs in the aggregates, we used fluores-
cence-activated cell sorting (FACS) to isolate hPGCLCs
expressing the cell surface receptors integrin alpha 6
(ITGA6) and epithelial cell adhesion molecule (EPCAM)
(Figure 2B). Our results showed that Ctrl UCLA1 and
UCLA6 hESCs had a clearly defined ITGA6/EPCAM dou-
ble-positive hPGCLC population at day 4 of differentiation
(Figure 2B), whereas all three T28KO sublines did not pro-
duce hPGCLCs (Figure 2B); we quantified the percentages
of the double-positive populations (Figure 2C). Therefore,
TRIM28 null hESCs cultured in the primed state of pluripo-
tency have lost germline competency.
Given that T28KO hESCs are germline incompetent, we
hypothesized that there might be also somatic lineage
bias, particularly given the pigmented teratomas. To
address this, we performed spontaneous embryoid body
(EB) differentiation and real-time PCR to examine
ectoderm, mesoderm, and endoderm induction at days 2
and 5 of EB differentiation (Figures S2B–S2D). We discov-
ered some gene-specific differences between T28KO and
Ctrl EBs, but collectively ectoderm (SOX1, PAX6, and
ZIC1), endoderm (SOX17, GATA6, and FOXA1), and
Figure 1. TRIM28 Is Not Required for Primed hESC Self-Renewal or Pluripotency
(A) Western blot to detect TRIM28 in control UCLA1 (Ctrl UCLA1), TRIM28KO #9 and #11 in UCLA1 (T28KO(U1-9) and T28KO(U1-11)),
control UCLA6 (Ctrl UCLA6), and TRIM28KO in UCLA6 (T28KO(U6)) primed hESCs. The top band represents the expected full-length TRIM28
protein (110 kDa). ACTIN is an internal loading control.
(B) Average cell counts over 7 days of control (Ctrl UCLA1) and T28KO (T28KO(U1-9)) primed hESC culture (n = 3 independent
experiments), *p < 0.05. Error bars represent SD.
(C) Representative immunofluorescence for OCT4 (red), TRIM28 (green), and nuclei (DAPI). Scale bar, 10 mm.
(D) Representative images of H&E-stained teratoma sections from control (Ctrl UCLA1) and T28KO (T28KO(U1-9)) hESCs (n = 6 teratomas).
Scale bar, 50 mm.
See also Figure S1.mesoderm (MIXL1 and TBX3) genes were induced into
T28KO EBs (Figures S2B–S2D). One transcription factor,
HAND1, was consistently lower in T28KO EBs at days 2
and 5 of EB differentiation experiments relative to Ctrls,
suggesting that mesoderm cell lineage differentiation
requiring HAND1 (for example, the differentiation of
cardiomyocytes) could be compromised. To address this,
we performed directed differentiation into cardiomyo-cytes (CMs), and showed that the percentage of CMs
was similar between Ctrl and T28KO at day 14 of differen-
tiation (Figures S2E and S2F). However, when normalized
to the total number of undifferentiating hESCs used to
initiate CM differentiation, the ratio of CMs generated
per input of hESCs was significantly lower in T28KOs
(Figure S2G). Taken together, a null mutation in TRIM28
had almost no effect on the basic properties of hESCStem Cell Reports j Vol. 10 j 243–256 j January 9, 2018 245
Figure 2. TRIM28KO hESCs Are Germline
Incompetent
(A) Schematic description of hPGCLC
differentiation.
(B) Representative flow-cytometry plots
of day-4 aggregates in Ctrl UCLA1,
T28KO(U1-9), T28KO(U1-11), Ctrl UCLA6,
and T28KO(U6). The hPGCLC population is
circled.
(C) Average percentage of hPGCLCs at day 4
of aggregate differentiation in paired ex-
periments of T28KO(U1-9) (n = 6 indepen-
dent experiments) with Ctrl UCLA1 (n = 6
independent experiments), T28KO(U1-11)
(n = 3 independent experiments) with Ctrl
UCLA1 (n = 3 independent experiments),
and T28KO(U6) (n = 3 independent experi-
ments) with Ctrl UCLA6 (n = 3 independent
experiments), **p < 0.01, *p < 0.05. Error
bars represent SD.
See also Figure S2.self-renewal, and instead affects germline competency
and the ability to maintain certain cell types derived
from mesoderm, most notably CMs.
TRIM28 Is Required to Repress HERVHs, SVAs, and
ZNFs in Primed hESCs
Previous studies found that TRIM28 is bound to the
chromatin of primed hESCs, and is specifically enriched
at HERVs, LTRs, and SVA (SINE-R, VNTR, and Alu) TE
subfamilies (Theunissen et al., 2016 and Figure S3A). To
examine how a null mutation in TRIM28 affects TE
expression, we performed RNA sequencing (RNA-seq) and
discovered that T28KO hESCs had an abundance (10,949)
of differentially expressed TEs (DETEs) with a smaller
number (670) of differentially expressed genes (DEGs)
relative to Ctrl cells (Figure 3A; Tables S1 and S2). One of
the DEGs was TRIM28 (Figure S3B). Enrichment analysis
of the DETEs revealed that this group was highly enriched
in HERV, LTR, and SVAs as anticipated from chromatin246 Stem Cell Reports j Vol. 10 j 243–256 j January 9, 2018immunoprecipitation sequencing (ChIP-seq) of TRIM28
in wild-type primed hESCs (Figure 3B).
Given the dynamic expression of HERVH and HERVK in
human pre-implantation embryos and the re-expression of
SVAwhen primed hESCs are switched to the naive state, we
focused specifically on these subfamilies. Using the ChIP-
seq dataset of Theunissen et al. (2016), we identified
expressed HERVH, HERVK, and SVA TEs that were previ-
ously reported as being bound by TRIM28 in primed hESCs
(Theunissen et al., 2016). Of the 1,400 expressed HERVH
sequences in our RNA-seq dataset (where expression was
>10 reads in at least one library) only 81 were bound by
TRIM28, and on average these TEs were derepressed in
T28KO hESCs relative to Ctrls (Figures 3C and S3C). In
contrast the 169 TRIM28-bound HERVKs were unchanged
(Figures 3D and S3D). Similar to HERVH subfamily mem-
bers, the 293 TRIM28-bound SVAs were also significantly
upregulated in T28KOs relative to Ctrls (Figure 3E). There-
fore, TRIM28 had subfamily-specific effects on TE
Figure 3. TRIM28 Is Required to Repress HERVH and SVA Family Members in Primed hESCs
(A) RNA-seq was used to detect DEG (n = 670) and DETE (n = 10,949) between Ctrl and T28KO(U1-9) primed hESCs.
(B) Enrichment analysis of the DETE between Ctrl and T28KO(U1-9) primed hESCs in TE subfamilies. Fold enrichment is represented as
log2(T28KO/Ctrl).
(C–E) Box plots of TRIM28-enriched HERVH, HERVK, and SVA expression in Ctrl and T28KO(U1-9) primed hESC. ‘‘TRIM28 enriched’’ denotes
any expressed HERVH/HERVK/SVA that were also defined as being bound by TRIM28 in wild-type primed hESC using the ChIP-seq dataset of
Theunissen et al. (2016). RPKM, reads per kilobase of transcript per million mapped reads.
(F–K) Meta-plots showing the correlations between TRIM28 binding and chromatin accessibility at HERVH, HERVK, and SVA family members
in Ctrl and T28KO(U1-9) primed hESCs. The four points on the x axis show, from left to right, 5 kbp upstream of TE, 50 end of TE, 30 end of TE,
and 5 kbp downstream of TE.
See also Figure S3.expression in primed hESCs, most notably repressing
SVAs and HERVH TEs, with limited effects on HERVK
RNA expression.
To determine how a TRIM28 deletion affects chromatin
accessibility, we performed an assay for transposase-acces-
sible chromatin sequencing (ATAC-seq) and showed that
chromatin accessibility was also dynamically changed in
the TE subfamily members bound by TRIM28 (Figures 3F–
3K). Specifically, the 50 end of HERVH exhibited increased
accessibility in T28KO hESCs relative to Ctrl cells, and
these new regions of accessibility occurred on average
2 kb upstream of the TRIM28 binding site (Figure 3F).
The TRIM28 bound HERVK subfamilies exhibited
increased accessibility exclusively at the 30 but not the 50
end of the TE (Figure 3H). ChIP-seq of TRIM28 in wild-
type cells shows that TRIM28 is bound to both ends ofthe element (Figure 3I), and this might explain the lack
of HERVK expression defects in T28KO hESCs with only
one of the two ends becoming more accessible. TRIM28
bound SVA elements exhibit a mild increase in accessibility
across the element body, consistent with TRIM28 binding
across the element body in wild-type hESCs (Figures 3J
and 3K). Taken together TRIM28-bound TEs show differ-
ences in accessibility upon deletion of TRIM28.
Given that TRIM28 is mostly enriched at TEs, yet we
discovered 670 DEGs (Table S1), we evaluated the correla-
tion betweenDETEs and their nearest neighborDEGs given
that LTRs can function as promoters and enhancers
(Rotman et al., 1986). Consistent with previous studies,
our data indicate that at short ranges (within 5 kb),
neighboring DEGs are highly correlated with differentially
expressed LTRs (r = 0.71) or differentially expressed HERVsStem Cell Reports j Vol. 10 j 243–256 j January 9, 2018 247
Figure 4. TRIM28 Regulates Local DNA
Methylation Levels at LTRs, HERVKs, and
LINEs in Primed hESCs
(A) Quantification of CpG methylation using
whole-genome bisulfite sequencing (WGBS)
in 528,773 common CpGs for both Ctrl and
T28KO(U1-9) primed hESCs (n = 2 indepen-
dent replicates).
(B) Venn diagram showing the overlap
between TRIM28 binding sites in control cells
using the dataset of Theunissen et al. (2016)
and the emergence of new ATAC-seq peaks in
T28KO(U1-9) hESCs.
(C) Percent CpG methylation levels at the 477
overlapping regions in Ctrl and T28KO(U1-9)
hESCs from (B).
(D–F) Percent CpG methylation levels of
HERV, LTR, and LINE from the 477 over-
lapping regions in Ctrl and T28KO(U1-9)
hESC. Asterisk indicates that HERVs are
mainly composed of HERVK.
See also Figure S4.(r = 0.58) (Figures S3G and S3H). At increasing distances
this correlation diminishes (10 kb, r = 0.35 and 20 kb,
r = 0.27 for LTRs). Therefore, similar to reports in the
mouse, DEGs in the T28KO hESCs may be explained by
the creation of new short-range promoters/enhancers at
LTRs and HERVs of neighboring genes.
To determine whether there were any functional groups
significantly enriched in the DEGs, we performed gene
ontology analysis. To our surprise, we discovered that the
DEGs were highly enriched in genes that encoded for
Kru¨ppel-associated box domain-containing zinc-finger
proteins (KRAB-ZNFs) (Figure S3I). There are 423 KRAB-
ZNF genes located in 25 major clusters scattered around
the human genome (Huntley et al., 2006). A subset of
ZNF genes in a human erythroleukemic cell line was
previously reported as being co-occupied by TRIM28,
SETDB1, ATRX, and ZNF274 (Valle-Garcı´a et al., 2016).
ZNF274 is expressed in undifferentiated hESCs but is not
differentially expressed in T28KO hESCs, so our results
cannot be explained by the repression of ZNF274.
To determinewhether TRIM28 is enriched in the 30 exons
of the differentially expressed ZNFs, we first examined
TRIM28 binding at the 728 ZNF genes identified by Valle-
Garcı´a et al. (2016) in somatic cells (Figure S3J). Our data
show a modest yet significant enrichment (p = 0.002) of
TRIM28 at the 50 differentially expressed ZNFs in common248 Stem Cell Reports j Vol. 10 j 243–256 j January 9, 2018with this dataset, which was mostly in the 30 exons, as well
as across the gene body (Figure S3K); the control gene set
are ZNFs that show no differences in gene expression
between Ctrl and T28KO hESCs (log2 fold change < 0.1).
Therefore, we speculate that TRIM28 directly regulates a
subset of ZNFs in primed pluripotent stem cells, and loss
of TRIM28 is associated with their increased expression.
Taken together, our data show that TRIM28 has subfam-
ily-specific effects on TE expression in primed hESCs,
most notably at HERVHs, LTRs, and SVAs. We also discov-
ered that the genes regulated by TRIM28 include the
ZNFs, which encode the sequence-specific binding partner
KRAB-ZNF transcriptional regulators.
TRIM28 Regulates DNA Methylation and Chromatin
States at LTRs, HERVKs, and LINEs in Primed hESCs
Previous studies have identified a complex relationship
between DNA methylation and TRIM28 in the mouse
embryo (Quenneville et al., 2012; Schultz et al., 2002;
Zuo et al., 2012). Here, we examined how a null mutation
in TRIM28 affects DNA methylation in primed hESCs.
To achieve this, we performed whole-genome bisulfite
sequencing (WGBS) of T28KO andCtrl hESCs, and showed
that global DNA methylation levels at CpGs sites remain
high at >80% (Figure 4A). To examine DNA methylation
levels at regions specifically bound by TRIM28, we first
Figure 5. TRIM28 Is Required to Maintain DNA Methylation at Paternal but Not Maternal ICRs in Primed hESCs
(A and B) TRIM28 binding at the IG-DMR and the H19-ICR relative to the average TRIM28 binding at 29 maternal ICRs as a control. ICR is
underlined.
(C) Percent CpG methylation levels at maternal imprinted ICRs in Ctrl and T28KO(U1-9) primed hESCs (n = 29 maternal ICRs), ns, not
significant. Error bars represent SD.
(D) Browser view of ATAC-seq (blue), WGBS (green), and TRIM28 ChIP-seq (yellow) at the IG-DMR ICR, the MEG3 promoter, and the
H19 ICR.
(legend continued on next page)
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identified all the TRIM28 bound regions that show
increased accessibility in the T28KO hESCs (Figure 4B).
Critically we discovered that only a small fraction of
TRIM28 bound regions (477/7,885; 6%) exhibit a signifi-
cant increase in chromatin accessibility (fold change
R 8, p < 0.05) relative to Ctrl cells. Intriguingly, even
though the 477 TRIM28 bound regions had increased
accessibility, we discovered a more significant effect on
the regions not bound by TRIM28. Specifically, we show
that 2,224 new ATAC-seq peaks are gained in the T28KO
hESCs relative to Ctrl (Figure 4B). In the current analysis,
we focused on the 477 regions that were bound by
TRIM28, and gained accessibility in the T28KO hESCs.
Using the WGBS dataset, we show that the average DNA
methylation levels of the 477 differentially accessible re-
gions were significantly lower in T28KO hESCs compared
with Ctrls (Figure 4C). Using enrichment analysis, we
discovered that these 477 regions were enriched in HERVs,
LTRs, and LINE elements (Figure S4A and Table S3). Box-
plot analysis shows that average DNA methylation levels
were dramatically reduced in HERVs, LTRs, and LINEs in
T28KO compared with Ctrl hESCs (Figures 4D–4F). Further
analysis of the hypomethylated HERVs (which are mainly
composed of HERVKs) showed that their expression
levels are unaffected between Ctrl and T28KO primed
hESCs (Figure S4B).
In addition to the 2,224 new ATAC-seq peaks in T28KO
hESCs, we also discovered a large number of peaks (1,849)
(Table S3) that changed from accessible in Ctrls to inacces-
sible in the T28KO hESCs. None of these peaks overlapped
withTRIM28binding byChIP-seq (Theunissen et al., 2016).
Loss of accessibility was particularly enriched in promoters,
exons, 50 UTRs, and coding regions (Figure S4C). To deter-
mine how decreased accessibility in gene promoters corre-
sponded to changes in DNA methylation, we calculated
the average DNA methylation in the accessible promoters
in Ctrl hESCs and the corresponding DNA methylation
levels of these same inaccessible promoters in T28KOhESCs
(n = 121 promoters). We discovered that in Ctrl cells these
promoters began with low levels of DNA methylation,
whereas in T28KO hESCs the promoters switch from low
to high levels of DNA methylation (Figures S4D and S4E).
Similarly, promoters that switch from inaccessible to acces-
sible in T28KOhESCs switch fromhigh to low levels ofDNA
methylation (Figures S4D and S4E), indicating that the
chromatin accessibility in promoters is clearly inversely
correlated with DNA methylation.(E and F) Relative expression using real-time RT-PCR of MEG3 and H
Error bars represent SD.
(G–J) ChIP-qPCR of TRIM28 and H3K9me3 at the MEG3 promoter and
(K) Sanger sequencing of SNPs in primed Ctrl and T28KO(U1-9) hESCs a
two independent H19 SNPs.
250 Stem Cell Reports j Vol. 10 j 243–256 j January 9, 2018TRIM28 Is Required to Maintain DNA Methylation at
Paternal but Not Maternal ICRs in Primed hESCs
Given previous reports that TRIM28 is required tomaintain
DNA methylation at IAPs in mouse embryos and also at
ICRs (Alexander et al., 2015; Messerschmidt et al., 2012;
Quenneville et al., 2011), we next evaluated the role of
TRIM28 at ICRs in primed hESCs. Notably, TRIM28 is not
enriched at any of the maternal ICRs in primed hESCs
(n = 29) and instead is only enriched at the two paternal
ICRs called IG-DMR (Figure 5A) and theH19 ICR (Figure 5B).
This result is different from that in the mouse where
TRIM28 is enriched at both maternal and paternal ICRs
in mouse embryos (Alexander et al., 2015; Messerschmidt
et al., 2012).
Next we evaluated DNA methylation levels at the
maternal and paternal ICRs in Ctrl and T28KO hESCs. We
discovered variable imprinting methylation levels at indi-
vidual ICRs in hESCs as previously reported (International
Stem Cell Initiative et al., 2007; Pastor et al., 2016; Rugg-
Gunn et al., 2007). However, on average, DNAmethylation
levels at maternal ICRs in Ctrl and T28KO hESCs were
around50% (Figure 5C). At theMEG3paternallymethylated
imprinted locus, we discovered that the IG-DMR and the
MEG3 promoter were demethylated in the T28KOs, relative
to Ctrls, and this was associated with increased chromatin
accessibility (Figure 5D). A similar change in chromatin
was also observed at the H19 ICR (Figure 5D). Consistent
with demethylation and the emergence of accessible
chromatin, the expression levels of MEG3 and H19 RNA
transcripts were both increased in T28KO cells relative to
Ctrls (Figures 5E and 5F). Taken together, our results suggest
that TRIM28 is required to continually target the paternal
ICRs for DNA methylation. Critically, maternal ICRs in
hESCs do not require TRIM28 to remain methylated.
To determine whether the effects at the MEG3 promoter
were direct, we evaluated TRIM28 binding by chromatin
immunoprecipitation followed by PCR (ChIP-qPCR) (Fig-
ure 5G). Our results show that TRIM28 is bound at the
MEG3 promoter in Ctrl cells, with no binding in the
T28KOs. Therefore TRIM28 is most likely acting on both
the IG-DMR and the MEG3 promoter. Similarly, we also
confirmed that TRIM28 is bound at the H19 ICR in Ctrl
hESCs (Figure 5H), and this binding is lost in the
T28KOs. We also performed ChIP-qPCR for histone h3
lysine 9 trimethylation (H3K9me3), which is a known
effector of TRIM28 binding on account of TRIM28’s inter-
action with SETDB1 (Schultz et al., 2002). Our data show19 in T28KO(U1-9) primed hESCs relative to Ctrl. ****p < 0.0001.
H19-ICR, in Ctrl and T28KO(U1-9) hESCs.
nd naive hESCs as a control for biallelic expression. Arrows indicate
Figure 6. Naive hESCs Are Dependent upon TRIM28 for TE Repression but Not Self-Renewal
(A) Morphology of 5iLAF reverted Ctrl and T28KO(U1-9) naive hESCs. Scale bars, 100 mm.
(B) RNA-seq of Ctrl and T28KO(U1-9) naive hESCs showing DEGs (n = 1,638) and DETEs (n = 12,350).
(legend continued on next page)
Stem Cell Reports j Vol. 10 j 243–256 j January 9, 2018 251
that H3K9me3 is also reduced at the MEG3 promoter, as
well as the H19 ICR in T28KO cells (Figures 5I and 5J). To
determine whether this loss of methylation affects allelic
expression, we examined the SNP in the H19 RNA tran-
scribed in the UCLA1 hESC line (Pastor et al., 2016). Using
these SNPs as a reference, we show that TRIM28 is required
to prevent loss of imprinting and maintain monoallelic
expression of H19 in self-renewing hESCs (Figure 5K).
Taken together, TRIM28 plays highly localized and precise
roles in the paternallymethylated ICRs where it acts to pro-
mote H3K9me3 andDNAmethylation in the self-renewing
primed state.
TRIM28 Represses a Broad Range of Transposable
Elements in Naive hESCs
Major transcriptional and epigenetic changes occur when
primed hESCs are reverted to the naive state. Most notably,
ICRs lose DNA methylation, LTR7-HERVH TEs are
repressed, and SVA TEs are induced (Pastor et al., 2016;
Theunissen et al., 2016). To evaluate the effects of
TRIM28 upon reversion to the naive state, we reverted
Ctrl and T28KO hESCs in the ground-state naive medium
called 5iLAF (Theunissen et al., 2014). Starting from
passages 3–5 post reversion, both Ctrl and T28KO putative
naive hESC exhibited typical small, round colonies (Fig-
ure 6A). We have successfully generated naive hESC lines
from both T28KO(U1-9) and T28KO(U1-11) primed hESCs
(data not shown). RNA-seq of stage-specific embryonic
antigen 4 (SSEA4)-negative, TRA-1–85-positive naive
hESCs (Pastor et al., 2016) from Ctrl and T28KO 5iLAF cul-
tures revealed that primed-specific genes OTX2, ZIC2,
ZIC3, and ZIC5 were downregulated in naive T28KO and
Ctrl hESCs, whereas the naive-specific genes KLFs,
DPPA3, and TFCP2L1 were significantly upregulated. The
RNA-seq analysis did reveal that T28KO naive hESCs had
lower average expression of NANOG (fold change = 1.82)
and DPPA3 (fold change = 1.80) compared with Ctrl hESCs
(Figure S5A), although this did not reach statistical signifi-
cance (defined as fold change R 2, false discovery
rate < 0.05). No morphological differences in colonies
were observed between Ctrl and T28KO naive hESCs under
phase-contrast microscopy, suggesting that a null muta-
tion in TRIM28 is also compatible with naive stem cell
self-renewal in human. However, we did discover that
T28KO naive hESCs grow more slowly than Ctrl naive(C) Box plots showing percentage of CpG methylation levels in
(n = 2 independent samples of each genotype in each pluripotent s
(D–G) Scatterplots showing selected DETEs between Ctrl and T28KO(
significantly downregulated; black dots, unchanged. Expression value
(H–K) Percent CpG methylation of TEs shown in (D) to (G). Dotted lin
(L) Representative tracks of RNA-seq, WGBS, and ChIP-seq at a repres
See also Figure S5.
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hybridization (aCGH) to determine copy number variants
(CNVs) in these two cell lines, which showed that the
naive Ctrl hESCs have normal CNVs while the T28KO
naive hESCs have two deletions at chromosome 20 and
chromosome 22 that do not overlap with normal CNVs
(Figure S5C).
Although TE expression is altered in primed hESCswith a
nullmutation inTRIM28, ChIP-seq data of TRIM28 inwild-
type 5iLAF cultures shows that significantly more TEs are
bound by TRIM28 under 5iLAF naive conditions (Fig-
ure S5D). Consistent with this, reverting TRIM28 null
hESCs to the naive state results in 12,350 DETEs (Figure 6B
and Table S2). Enrichment analysis of the DETE identified
HERVand LTR families, as well as SVAs (Figure S5E). Similar
to the effects of TRIM28 on primed hESCs, we also discov-
ered 1,638 DEGs (Figure S5F).
We next evaluated changes in DNAmethylation in naive
T28KO cells relative to Ctrl cells (Figure 6C). As expected,
reversion to the naive state also resulted in a global loss
of DNA methylation from an average of 74.5% in primed
cells to an average of 42.4% in the naive state. In naive
T28KO hESCs we discovered that DNA methylation was
also globally reduced (Figure 6C). However, the average
levels of global DNA methylation were slightly higher in
the naive T28KOs (50.15% versus 42.4%). This translated
to significantly more hypermethylated DMRs in the
T28KOhESCs (2,552) and only a small number of hypome-
thylated regions (578). Notably, the hypomethylated
DMRs were particularly enriched in SVAs and HERVs
(Figure S5G and Table S3).
To determine the relationship between TRIM28 andDNA
methylation in the hypomethylated naive state, we
combined the ChIP-seq dataset of TRIM28 in naive hESCs
(Theunissen et al., 2016), with the RNA-seq and WGBS
data of T28KO and Ctrl naive hESCs generated in this
study. This comparison identified subfamilies of TRIM28
bound HERVHs, HERVKs, and SVAs that were significantly
affected at both the RNA and DNA methylation level
(Figures 6D–6K and Table S4). Notably, HERVH family
members were both up- and downregulated in T28KO
hESCs (Figure 6D), with upregulated HERVHs exhibiting
an extra peak of TRIM28 binding in wild-type cells (Figures
S5H and 6L). Of the 60 HERVH elements that were identi-
fied as upregulated in primed hESCs, 15 of 60 remainedCtrl and T28KO(U1-9) hESCs in the primed and naive states
tate).
U1-9) naive hESCs. Red dots, significantly upregulated; blue dots,
s are represented as RPKM.
es, CpG methylation in T28KO; solid lines, the same regions in Ctrl.
entative HERVH, HERVK, and SVA.
upregulated following reversion to the naive state. How-
ever, 60 HERVH family members were newly upregulated
in naive T28KO hESCs relative to Ctrl, including the
primed-specific LTR7-HERVHs (Table S4). Similarly LTRs
were also highly enriched in TRIM28 binding in the naive
state, and consistent with this, T28KO naive cells had
increased RNA expression from LTRs (Figure 6E). Interest-
ingly, the differentially upregulated LTRs did not show
obvious loss of DNA methylation below the genome
average, indicating that LTRs are regulated primarily by
TRIM28 (Figure 6I). In the primed state, TRIM28 null muta-
tions had no significant effect on HERVK RNA expression
(Figure 3D). In contrast, HERVK elements were now dere-
pressed in T28KO naive hESCs relative to Ctrls (Figure 6F),
and this was also accompanied by changes in DNAmethyl-
ation (Figures 6J and 6L). Therefore, expression of HERVK
subfamily members was particularly sensitive to loss of
TRIM28 in the naive state compared with the primed state.
Although naive human pluripotency under wild-type
conditions is associated with expression of SVAs at the
expense of LTR7-HERVH, a TRIM28 null mutation in naive
hESCs leads to further upregulation of SVA familymembers,
and this is associated with loss of methylation particularly
at their 50 regions (Figures 6G and 6K). Taken together,
TRIM28 has an important role in regulating the expression
andDNAmethylation levels of TEs in thenaive state, partic-
ularly the repression of LTR7-HERVHs, HERVKs and SVAs.DISCUSSION
In the current study, we show that self-renewal of hESCs in
the naive and primed states of human pluripotency are
compatible with significant changes in TE expression,
accompanied by changes in chromatin accessibility and
DNA methylation, particularly at HERVs and LTRs. This
result is unlike the biological response in mouse pluripo-
tent cells, where a Trim28 null mutation in mouse cells is
incompatible with mouse ESC self-renewal and mouse
embryo development (Cammas et al., 2000; Rowe et al.,
2010). One explanation for these species-specific differ-
ences in response to loss of TRIM28 is that the primed state
of hESC pluripotency is more similar to mouse epiblast
stem cells (EpiSCs) than mouse ESCs (Tesar et al., 2007).
Generating a TRIM28 null mutation in mouse EpiSCs in
future studies will address this issue.
It is also possible that the modest biological effect on
human pluripotent stem cell self-renewal in the absence
of human TRIM28 relative to the mouse is a consequence
of the unique repertoire of provirus that infected and
expanded in rodent genomes relative to humans, where
it is possible that the rodent TEs today are more mutagenic
and/or deleterious when derepressed in the absence ofTRIM28 (Dewannieux et al., 2004; Zhang et al., 2008). In
the human genome, most TEs are ancient non-functional
relics of past proviral infections that have lost transposition
competency. Furthermore, our data also suggest that the
continued targeting of TRIM28 to TE-associated chromatin
is not the primary defense formost TE repression in human
pluripotent stem cells, because a large fraction of the
TRIM28-bound TEs remained unperturbed in both the
primed and the naive state when TRIM28 was deleted.
Given that hESCs with a TRIM28 null mutation are
biased against hPGCLC differentiation, we speculate that
this occurs as an unintended consequence of dynamically
changing accessibility of local chromatin in human primed
pluripotent hESCs. The differentiation of hPGCLCs from
pluripotent stem cells requires a narrow window in devel-
opment where the same signaling pathways used to
generate primitive streak (notably, ACTIVIN, WNTs, and
bone morphogenetic protein 4 [BMP4]) are also required
to specify hPGCLCs. It was previously reported that
changes to the concentrations of growth factors that
promote hPGCLC differentiation also significantly affect
germline competency (Sasaki et al., 2015). We propose
that for lineages where the window for competency is
very narrow (such as the allocation of hPGCLCs from
hESCs), small changes in the response to somatic cell
signaling cues bias against germline fate.
We also discovered that unlike mouse ESCs where mouse
TRIM28 regulates DNA methylation at almost all ICRs
(Alexander et al., 2015), human TRIM28 is only responsible
for regulating DNA methylation at the paternally methyl-
ated ICRs in human pluripotent stem cells. Previous studies
have shown that ICR methylation in primed hESCs is not
regulated by the de novoDNAmethyltransferases DNMT3A
or DNMT3B (Liao et al., 2015). These results may suggest
that DNMT1 re-targets discrete paternal ICRs and pro-
moters together with TRIM28 outside of replication-
coupled DNA methylation maintenance, given that the
paternally methylated ICRs were so specifically and
discretely targeted. Alternatively, it is conceivable that a
previously undiscovered DNMT may have evolved to
interact with TRIM28 to target DNA methylation specif-
ically to paternal ICRs.
TRIM28 itself has no sequence specificity. Instead,
TRIM28 binds to ZNFs, which target TRIM28 to discrete
sites in a sequence-dependent manner. The ZNF respon-
sible for targeting TRIM28 to ICRs in the mouse genome
(ZFP57) is also responsible for some ICR methylation in
the human genome. Specifically, a homozygous deletion
of ZFP57 in human is compatible with life, germ cell
development, and fertility, with homozygous children
exhibiting variable ICR hypomethylation mostly at
maternal ICRs (Mackay et al., 2008). In light of our findings
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methylation in a TRIM28-independent mechanism, or
alternatively that TRIM28 targets paternal ICRs by a
ZFP57-independent mechanism. Future studies could be
designed to address these hypotheses.
Previous reports have shown that in the majority of
reversions in 5iLAF, hESCs exhibit karyotypic instability
(Pastor et al., 2016; Theunissen et al., 2014). In the current
study, the Ctrl naive hESCs had a normal karyotype based
on CNV analysis. However, we discovered that the T28KO
naive hESCs cultured under identical conditions developed
abnormal CNVs. It has previously been reported that SVA
expression causes genome instability and even diseases
(Kaer and Speek, 2013). Therefore, we hypothesize that
one of the possible mechanisms associated with increased
genome instability may be due to increased SVA expression
in the naive state.
Taken together, TRIM28 has broadly conserved roles in
human and mouse pluripotent stem cells where it func-
tions to regulate TE expression, and this is associated
with changes in the landscape of chromatin accessibility
and DNA methylation. However, our data also highlight
species-specific differences in the naive state of pluripo-
tency including the finding that human naive pluripotent
stem cells tolerate significant changes in TE expression
downstream of a TRIM28 mutation. We also show, surpris-
ingly, that TRIM28 has a preference for targeting paternal
ICRs in the primed self-renewing state rather than ICRs
more broadly. We were also able to uncover a role for
TRIM28 in germline competency, and future studies will
involve identifying the ZNFs responsible for these different
phenotypes.EXPERIMENTAL PROCEDURES
Primed and Naive hESC Culture
Primed and naive hESCs were cultured as previously described
(Pastor et al., 2016). See Supplemental Experimental Procedures
for details. All hESC studies were approved by the UCLA
Embryonic Stem Cell Research Oversight (ESCRO) Committee.
Generation of TRIM28 Knockout Primed hESC Line
Taking advantage of the CRISPR/Cas9 targeting technology in
mammalian cells (Cong et al., 2013), we designed paired gRNAs
that target exon 4 and exon 11 of the human TRIM28 genome,
respectively, using the crispr.mit.edu web site, and ligated the
gRNAs with px459 vector to obtain the final constructs. Two
micrograms of each targeting vector (4 mg in total) were electropo-
rated into 800K human ESCs, and we used the P3 Primary Cell
4D-Nucleofector X Kit to perform the nucleofection following
manufacturer’s instructions. The cells were transferred to one well
of a 24-well plate with feeders post nucleofection, and on the
next day, 0.35 mg/mL puromycin was added to the medium as a
primary screen of successfully electroporated cells for 24 hr. The
medium was then changed back to regular hESC medium + ROCKi254 Stem Cell Reports j Vol. 10 j 243–256 j January 9, 2018for another 3 days until cells were densely grown. Cells were then
split by Accutase and transferred as 2K and 10K per dish onto
10-cm dishes with feeders. After 10–14 days when the colonies
were big enough, single colonies were picked manually, and the
genomic DNA of each line was extracted and genotyped. The
homozygous TRIM28 knockout lines were then expanded for
further analysis. The gRNA sequences are: 50-ACG TTC ACC ATC
CCG AGA CT-30 for exon 4 and 50-GGT GAG CGG CCT TAT GCG
CA-30 for exon 11.hPGCLC Differentiation
Primed hESCs were differentiated into hPGCLC as described in
Sasaki et al. (2015) with some modifications. Day-7 hESCs were
dissociated into single cells with 0.05% trypsin-EDTA (Gibco) and
plated onto a human plasma fibronectin (Invitrogen)-coated
12-well-plate at 200,000 cells/well cell density in 2 mL/well of
incipient mesoderm-like cells (iMeLCs) medium, which is
composed of 15% knockout serum replacement (KSR), 13 non-
essential amino acids (NEAA), 0.1 mM 2-mercaptoethanol,
13 penicillin-streptomycin-glutamine (Gibco), 1 mM sodium
pyruvate (Gibco), 50 ng/mL Activin A (Peprotech), 3 mM
CHIR99021 (Stemgent), 10 mM ROCKi (Y27632, Stemgent), and
50 ng/mL primocin in Glasgow’s minimal essential medium
(GMEM) (Gibco). Twenty-four hours later, iMeLCswere dissociated
into single cells by 0.05% trypsin-EDTA, followed by plating onto
ultra-low cell attachment U-bottom 96-well plates (Corning) at a
density of 3,000 cells/well in 200 mL/well of hPGCLC medium,
which is composed of 15% KSR, 13 NEAA, 0.1 mM 2-mercaptoe-
thanol, 13 penicillin-streptomycin-glutamine (Gibco), 1 mM
sodium pyruvate (Gibco), 10 ng/mL human leukemia inhibitory
factor (Millipore), 200 ng/mL human BMP4 (R&D systems),
50 ng/mL human epidermal growth factor (R&D Systems), 10 mM
of ROCKi (Y27632, Stemgent), and 50 ng/mL primocin in GMEM
(Gibco). Day-4 hPGCLC aggregates were used for further analysis.hPGCLC Flow-Cytometry Analysis
Day-4 hPGCLC aggregates were dissociated with 0.05% trypsin-
EDTA for 10 min at 37C. The dissociated cells were stained with
antibodies, which were INTEGRINa6 conjugated with BV421
(BioLegend) and EpCAM conjugated with 488 (BioLegend) for
at least 1 hr on ice. Cells were then washed with FACS
buffer (1% BSA in PBS) once and resuspended in FACS buffer
with 7-aminoactinomycin D (BD Pharmingen). Finally, cells were
passed through a 40-mm cell strainer (Fisher Scientific) and used
for flow-cytometric analysis.RNA-Seq
Cells were centrifuged and cell pellets lysed in 350 mL of RLT buffer,
and total RNAwas extracted using an RNeasymicro kit (Qiagen) or
RNeasy mini kit (Qiagen). cDNA was amplified using Ovation
RNA-Seq System V2 (Nugen) according to the manufacturer’s
instructions. Amplified cDNAwas then sheared to 200 bp length
by a Covaris S220 Focused ultrasonicator. RNA-seq libraries were
constructed by using Ovation Rapid Library Systems (Nugen,
0319-32 for index 1–8 and 0320-32 for index 9–16) and quantified
by a KAPA library quantification kit (Illumina). Libraries were
subjected to single-end 50-bp sequencing on a HiSeq 2500/4000
sequencer with 4–6 indexed libraries per lane.
ATAC-Seq
Cells were lysed directly in lysis buffer (500 mL 1 M Tris [pH 7.4],
100 mL 5 M NaCl, 150 mL 1 M MgCl2, 500 mL 10% NP-40 in
50 mL water). After centrifugation, the cell pellet was resuspended
in transposase buffer, which contained the Tn5 transposase
enzyme and tagmentation buffer (Nextera DNA library prep kit:
Illumina, catalog no. 15028212), and incubated at 37C for
30 min. After purification by a MinElute PCR Purification Kit 250
(Qiagen 28006), P1 barcode (25 mM) and appropriate P2 barcodes
(25 mM) were added to the DNA and run for five cycles of PCR
reaction (NEBNext High-Fidelity 23 PCR Master Mix; NEB,
M0541S). Ten percent of the PCR product was taken out for
real-time PCR analysis to determine the amplification cycles of
the library, followed immediately by PCR amplification of the
remaining library DNA. Libraries were subjected to paired-end
50-bp sequencing on a Hi Seq 4000 sequencer with 4–6 indexed
libraries per lane.
Whole-Genome Bisulfite Sequencing
DNA for bisulfite sequencing was extracted using the Quick gDNA
Mini-Prep Kit (Zymo D3025) and quantified using the Qubit
dsDNA High Sensitivity Kit (Life Technologies). Bisulfite
sequencing libraries were prepared using the Ovation Ultralow
Methyl-Seq Library System (Nugen, 0335 for DRMultiplex System
1–8, 0336 for DR Multiplex System 9–16). Libraries were subjected
to single-end 100-bp sequencing on HiSeq 4000 sequencer with
about 1 sample per lane to achieve coverage.
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